Exact Mass: 348.0463236
Exact Mass Matches: 348.0463236
Found 349 metabolites which its exact mass value is equals to given mass value 348.0463236
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Inosine 5'-monophosphate (IMP)
Inosinic acid, also known as inosine monophosphate, IMP, 5-inosinate or 5-IMP, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. IMP is also classified as a nucleotide (a nucleoside monophosphate). Inosinic acid exists in all living species, ranging from bacteria to plants to humans. IMP is widely used as a flavor enhancer. In the food industry it is known as E number reference E630. Inosinic acid can be converted into various salts including disodium inosinate (E631), dipotassium inosinate (E632), and calcium inosinate (E633). These three inosinate compounds are used as flavor enhancers for the basic taste umami. These inosinate salts are mostly used in soups, sauces, and seasonings for the intensification and balance of the flavor of meat. Inosinic acid is typically obtained from chicken byproducts or other meat industry waste. Inosinic acid or IMP is important in metabolism. It is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine nucleotides. It can also be formed by the deamination of adenosine monophosphate by AMP deaminase. GMP is formed by the inosinate oxidation to xanthylate (XMP). Within humans, inosinic acid participates in a number of enzymatic reactions. In particular, inosinic acid can be converted into phosphoribosyl formamidocarboxamide; which is catalyzed by the bifunctional purine biosynthesis protein. In addition, inosinic acid can be converted into xanthylic acid; which is catalyzed by the enzyme inosine-5-monophosphate dehydrogenase 1. Origin: Microbe; Formula(Parent): C10H13N4O8P; Bottle Name:Inosine-5-monophosphate; PRIME Parent Name:Inosine-5-monophosphate; PRIME in-house No.:0258, Purines A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map Acquisition and generation of the data is financially supported in part by CREST/JST. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.057 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Inosinic acid is an endogenous metabolite.
2-O-(6-Phospho-alpha-mannosyl)-D-glycerate
2-O-(6-Phospho-alpha-mannosyl)-D-glycerate is an alpha-D-mannosylglycerate (MG) that is an intermediate in 2-O-alpha-mannosyl-D-glycerate degradation. It can be generated from 2-O-alpha-mannosyl-D-glycerate via the enzyme 2-O-alpha-mannosyl-D-glycerate transporting phosphotransferase system (mngA). 2-O-Alpha-mannosyl-D-glycerate is a natural extremolyte identified in microorganisms growing under extremely high temperatures up to 100 oC, and had been shown to protect proteins against various stress conditions such as heat, freezing, thawing, and drying. MG that is naturally occurring hyperthermophilic osmolytes, could be potential drug candidates or lead compounds against alpha,beta aggregation associated with Alzheimers disease(PMID: 18304694). In most organisms MG is produced from guanosine pyrophosphate mannose (GDP-alpha-D-mannose) via mannosyl-3-phosphoglycerate in two steps, catalyzed by the enzymes mannosyl-3-phosphoglycerate synthase and mannosyl-3-phosphoglycerate phosphatase. [HMDB] 2-O-(6-Phospho-alpha-mannosyl)-D-glycerate is an alpha-D-mannosylglycerate (MG) that is an intermediate in 2-O-alpha-mannosyl-D-glycerate degradation. It can be generated from 2-O-alpha-mannosyl-D-glycerate via the enzyme 2-O-alpha-mannosyl-D-glycerate transporting phosphotransferase system (mngA). 2-O-Alpha-mannosyl-D-glycerate is a natural extremolyte identified in microorganisms growing under extremely high temperatures up to 100 oC, and had been shown to protect proteins against various stress conditions such as heat, freezing, thawing, and drying. MG that is naturally occurring hyperthermophilic osmolytes, could be potential drug candidates or lead compounds against alpha,beta aggregation associated with Alzheimers disease(PMID: 18304694). In most organisms MG is produced from guanosine pyrophosphate mannose (GDP-alpha-D-mannose) via mannosyl-3-phosphoglycerate in two steps, catalyzed by the enzymes mannosyl-3-phosphoglycerate synthase and mannosyl-3-phosphoglycerate phosphatase.
Doxefazepam
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal
alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde
alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde is considered to be slightly soluble (in water) and acidic
2-keto-3-deoxy-D-glycero-D-galacto-nononate 9-phosphate
Verinurad
D018501 - Antirheumatic Agents > D006074 - Gout Suppressants C26170 - Protective Agent > C921 - Uricosuric Agent
(2R)-2-(alpha-D-glucopyranosyloxy)-3-(phosphonooxy)propanoic acid
Succisulfone
C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent
5,7,8-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-methoxy-3,4-dihydro-2H-1-benzopyran-4-one
Inosine 2'-phosphate
Inosine 2-phosphate is an inosine nucleotide containing a pyrophosphate group esterified to C2 of the sugar moiety. Inosine 2-phosphate is a product of 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. 2,3-cyclic nucleotide 3-phosphodiesterase is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration. [HMDB] Inosine 2-phosphate is an inosine nucleotide containing a pyrophosphate group esterified to C2 of the sugar moiety. Inosine 2-phosphate is a product of 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. 2,3-cyclic nucleotide 3-phosphodiesterase is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration.
Glucose-6-phosphate lactate
[(2R,5R)-3,4-Dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate
Flavour enhancer
Cloxazolam, (R)-
N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Verinurad
D018501 - Antirheumatic Agents > D006074 - Gout Suppressants C26170 - Protective Agent > C921 - Uricosuric Agent
8-Demethylthymonin
8-demethylthymonin is a member of the class of compounds known as 7-o-methylated flavonoids. 7-o-methylated flavonoids are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. 8-demethylthymonin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 8-demethylthymonin can be found in common thyme, which makes 8-demethylthymonin a potential biomarker for the consumption of this food product.
Taiwanin C
A furonaphthodioxole that is furo[3,4:6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one substituted by a 1,3-benzodioxol-5-yl group at position 5. It is a naturally occurring lignan extracted from Taiwania cryptomerioides and found to be a potential inhibitor of COX2 expression.
Helioxanthin
A furonaphthodioxole that is furo[3,4:6,7]naphtho[1,2-d][1,3]dioxol-7(9H)-one substituted by a 1,3-benzodioxol-5-yl group at posiiton 10. It is a inhibitor of HBV, HCV and HSV-1 viruses.
2H-Naphtho[2,3-b]pyran-6,9-dione,3,4-dihydro-4,5,10-trihydroxy-8-methoxy-2-(2-oxopropyl)-,(2R,4S)-
2-(1,1-Dimethyl-2-propenyl)-3-[2-(methylformylamino)ethyl]-6-bromo-1H-indole
Dryopteric acid
2-[(4-Chlorophenyl)sulfonyl]-3-[(4,6-dimethylpyrimidin-2-yl)amino]acrylonitrile
C15H13ClN4O2S (348.04477080000004)
N-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfamoyl)phenyl]acetamide
3(2-Chlorophenyl)-7-hydroxy-4-phenylcoumarin
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.266 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.265 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.268
3-Benzyloxy-2-phenyl-benzo[b]thiophen-1,1-dioxid|3-benzyloxy-2-phenyl-benzo[b]thiophene 1,1-dioxide
18-Bromo-(17Z)-octadeca-17-ene-5,7,15-triynoic acid
Isobutyric acid (2,2:5,2-terthiophen-5-yl)methyl ester
(3,4,5-trihydroxy-6-methoxyoxan-2-yl)methyl 4-methylbenzenesulfonate
C14H20O8S (348.08788400000003)
1,3-Dihydroxy-2,4,5,7-tetramethoxy-9H-xanthene-9-one
5-acetoxymethylen-2-(4-acetoxy-but-3-inyl)-dithiophene|5-acetoxymethylen-2-<4-acetoxy-but-3-inyl>-dithiophene|Di-Ac-4-[5-(Hydroxymethyl)-[2,2-bithiophen-5-yl]]-3-butyn-1-ol
4-ethyl 4-methyl 2,3,5,6-tetrahydroxy[1,1-biphenyl]-4,4-dicarboxylate
Di-Ac-4-[5-Methyl-[2,2-bithiophen]-5-yl]-3-butyne-1,2-diol
crassifogenin C
A norlignan that is 3-deoxypentodialdo-5,4-oxirose substituted at positions 1 and 4 by 3,4-dihydroxyphenyl groups. It is isolated from the rhizomes of Curculigo crassifolia and exhibits strong radical scavenging activity.
(1R*,5S*,9S*,13R*,14R*)-11,14,16-trihydroxy-10,17-dimethyl-3,7-dioxapentacyclo[11.4.0.01,5.05,9.09,14]heptadeca-10,16-diene-4,12,15-trione|epicolactone
(5R,6R)-6-{2-[(1E)-1-(5-chloro-1H-pyrrol-2-yl)prop-1-en-2-yl]-1,3-oxazol-4-yl}-4-methoxy-5-methyl-5,6-dihydro-2H-pyran-2-one|pyrronazol B
methyl (R)-3-[2-(3,4-dihydroxybenzoyl)-4,5-dihydroxyphenyl]-2-hydroxypropanoate
(8beta)-10-bromo-3-chloro-2,7-epoxychamigr-9-en-8-ol|rel-(2R,3S,5aR,9S,9aR)-7-bromo-3-chloro-2,3,4,5,9,9a-hexahydro-3,6,6,9a-tetramethyl-6H-2,5a-methano-1-benzoxepin-9-ol
5-methyl-[5-(3-hydroxy-4-isovaleroxy-1-butynyl)]-2,2-bithiophene
C18H20O3S2 (348.08538100000004)
(7E,13E,17E)-form-18-Bromo-7,13,17-octadecatriene-5,15-diynoic acid
1-Hydroxy-3-methyl-8,10-dimethoxy-9-chlorodibenz[b,e]oxepin-6,11-dione
Chaetocyclinone A
An organic heterotricyclic compound that is 1H,10H-pyrano[4,3-b]chromene substituted by methoxy, methyl, hydroxy, methoxy, methoxycarbonyl, and oxo groups at positions 1, 3, 6, 7, 9 and 10, respectively. It is produced by cultures of Chaetomium sp. Goe 100/2, which was isolated from marine algae.
7-Methoxy-2-phenyl-3-sulfooxy-chromen-4-on|7-methoxy-2-phenyl-3-sulfooxy-chromen-4-one|rhamnocitrin 3-sulphate
2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid
2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid
5-hydroxy-2-(3-hydroxy-2-methoxycarbonyl-5-methylphenoxy)-3-methoxybenzoic acid
Inosinic acid
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Inosinic acid is an endogenous metabolite.
2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid [IIN-based: Match]
2-hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid [IIN-based on: CCMSLIB00000847922]
18-bromo-9E,15E,17E-octadecatrien-5,7-diynoic acid
1,1-Binaphthyl-2,2-diyl hydrogenphosphate
C20H13O4P (348.05514280000006)
2-(2-Fluoro-4-iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
3-(trimethylsilyl)-2-naphthyl trifluoromethanesulfonate
alpha-(4-Methoxybenzoyl)-2-chloro-4-nitroacetanilide
C16H13ClN2O5 (348.05129580000005)
Methanone,(7-bromo-2,3-dihydro-1,4-benzodioxin-6-yl)(2-methoxyphenyl)-
C16H13BrO4 (347.99971580000005)
1,6-Dideoxy-1,1-bis(ethylsulfonyl)-L-mannitol
C11H24O8S2 (348.09125439999997)
1-(4-chloro-3-isocyanatobenzenesulfonyl)-1,2,3,4-tetrahydroquinoline
C16H13ClN2O3S (348.0335378000001)
1,3-DIAMINO-4-(HEPTAFLUOROISOPROPYL)BENZENE DIHYDROCHLORIDE
C9H9Cl2F7N2 (348.00309780000003)
4,4-DIHYDROXYOCTAFLUORODIPHENYL MONOHYDRATE
C12H4F8O3 (348.00326899999993)
2-methoxy-6-[(4-methylphenyl)sulfonyloxymethyl]oxane-3,4,5-triol
C14H20O8S (348.08788400000003)
(R)-(-)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate
C20H13O4P (348.05514280000006)
(S)-(+)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate
C20H13O4P (348.05514280000006)
N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide hydrochloride
METHYL 4-(3-(4-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)BENZOATE
C17H11F3N2O3 (348.07217319999995)
2-ETHOXY-5-[(MORPHOLINE-4-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE
C13H17ClN2O5S (348.05466620000004)
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2-bipyrimidine
1,2,3,4,5,6-Cyclohexanehexacarboxylic acid
C12H12O12 (348.03287520000003)
Pifithrin-β (hydrobromide)
Pifithrin-β hydrobromide (PFT β hydrobromide) is a potent p53 inhibitor with an IC50 of 23 μM.
3-(5-Cyano-2-hydroxy-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-ylazo)benzenesulfonicacid
Ethyl 4-(3-bromo-4-formylphenoxy)benzoate
C16H13BrO4 (347.99971580000005)
2,2,3,3,4,4-hexafluoro-1,5-pentyl dimethacrylate
C13H14F6O4 (348.07962360000005)
5-(4-chlorophenyl)-N-quinolin-6-ylfuran-2-carboxamide
2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Glucopyranoside
C12H13FN2O9 (348.06050600000003)
4-AMINO-N-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)BENZAMIDE
10-(4-methylphenyl)-7-nitropyrimido[4,5-b]quinoline-2,4-dione
C18H12N4O4 (348.08585120000004)
(4-nitrophenyl)methyl 6-(1-hydroxyethyl)-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
N-([3,5-BIS(TRIFLUOROMETHYL)BENZOYL]OXY)-2-CHLOROETHANIMIDAMIDE
C11H7ClF6N2O2 (348.01002239999997)
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine
C15H10ClFN4O3 (348.04254319999995)
4-Oxo-2-phenyl-4H-chromen-3-yl 2-thiophenecarboxylate
6-(Trifluoromethyl)-2-pyridinemethanol 2-(4-methylbenzenesulfonate)
C14H13F3NO4S (348.05173540000004)
1-Piperazineethanol, 4-[(3-bromophenyl)sulfonyl]-
C12H17BrN2O3S (348.01431920000005)
3-(perfluorobutyl)-2-hydroxypropyl acrylate
C10H9F9O3 (348.04079519999993)
Diethyl2,6-bis(methylthio)-4-oxo-4H-thiopyran-3,5-dicarboxylate
1-Bromo-6-ferrocenylhexane 6-Ferrocenylhexyl bromide
(4R)-2-(2,3-dihydroxyphenyl)-N-hydroxy-N-[2-(1H-imidazol-5-yl)ethyl]-4,5-dihydro-1,3-thiazole-4-carboxamide
C15H16N4O4S (348.08922160000003)
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents
4-hydroxy-2-oxo-N-[3-(trifluoromethyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
C17H11F3N2O3 (348.07217319999995)
Lactucin 15-oxalate
A sesquiterpene lactone obtained by formal condensation of one of the carboxy groups of oxalic acid with the 15-hydroxy group of lactucin. Found in chicory.
5-[(6-Methoxy-1,3-benzothiazol-2-yl)amino]-3-methyl-2-thiophenecarboxylic acid ethyl ester
3-(2-Chlorophenyl)-7-hydroxy-4-phenylchromen-2-one
(5z)-3-(4-Chlorophenyl)-4-Hydroxy-5-(1-Naphthylmethylene)furan-2(5h)-One
2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Mannopyranoside
C12H13FN2O9 (348.06050600000003)
{[4-Amino-2-(3-chloroanilino)-1,3-thiazol-5-YL](4-fluorophenyl)methanone
Tolestan
N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
5-Hydroxy-2-(3-hydroxy-2-methoxycarbonyl-5-methylphenoxy)-3-methoxybenzoic acid
2-Hydroxy-6-(2-hydroxy-4-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid
D065128 - Endothelin Receptor Antagonists
2,4-DINITROPHENYL-2-FLUORO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE
C12H13FN2O9 (348.06050600000003)
3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid 9-phosphate
A ketoaldonic acid phosphate that is 3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid carrying a monophosohate substituent at position 9.
[5-(2,6-dioxo-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate
(2S)-5-[[(2R)-3-acetylsulfanyl-1-(carboxylatomethylamino)-1-oxopropan-2-yl]amino]-2-azaniumyl-5-oxopentanoate
(2R)-3-phosphonooxy-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanoic acid
[2,3,4,5-Tetrahydroxy-6-(phosphonooxymethyl)oxan-2-yl] 2-hydroxypropanoate
4-Chloro-6-[5-(4-ethoxyphenyl)-1,2,3-thiadiazol-4-yl]benzene-1,3-diol
C16H13ClN2O3S (348.0335378000001)
N-(bicyclo[2.2.1]hept-2-ylcarbonyl)-3-chloro-1-benzothiophene-2-carbohydrazide
5-[(3-chlorophenoxy)methyl]-N-(4-methyl-2-thiazolyl)-2-furancarboxamide
C16H13ClN2O3S (348.0335378000001)
4-Chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl ester
C16H13ClN2O5 (348.05129580000005)
(2-Methyl-3-imidazo[1,2-a]pyridinyl)-diphenyl-sulfanylidenephosphorane
({6-[4-(Methylsulfanyl)phenyl]thieno[3,2-d]pyrimidin-4-yl}sulfanyl)acetic acid
N1-Protonated adenosine-5-monophosphate
C10H15N5O7P+ (348.07090700000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-(4-Bromoanilino)-1-(3-nitrophenyl)-1-propanone
C15H13BrN2O3 (348.01094880000005)
N-(1,3-dioxo-2-phenyl-5-isoindolyl)-2-thiophenecarboxamide
C19H12N2O3S (348.0568602000001)
N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-2-thiophen-2-ylacetamide
4-chloro-3-nitrobenzaldehyde N-(4-methylphenyl)thiosemicarbazone
C15H13ClN4O2S (348.04477080000004)
4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]benzoic acid methyl ester
C15H12N2O6S (348.04160520000005)
2-Benzamido-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide
3-(2-chloro-6-fluorophenyl)-N-(2-hydroxy-5-methylphenyl)-4,5-dihydroisoxazole-5-carboxamide
N-[4-(4-fluorophenyl)-2-thiazolyl]-4-methylbenzenesulfonamide
C16H13FN2O2S2 (348.04024499999997)
N-[1-[(2-bromophenyl)methyl]-2-oxo-3-pyridinyl]butanamide
C16H17BrN2O2 (348.04733219999997)
N-[3-[(1,3-dioxo-5-isoindolyl)oxy]phenyl]-2-furancarboxamide
C19H12N2O5 (348.07461820000003)
2-[(5-amino-7-methyl-[1,2,4]triazolo[4,3-c]pyrimidin-3-yl)thio]-N-(4-chlorophenyl)acetamide
C14H13ClN6OS (348.05600380000004)
(3E)-N-(3,5-dichloroanilino)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine-3-carboximidoyl cyanide
N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide
N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide
N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide
N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide
N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide
N-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide
N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-4-chlorobenzenesulfonamide
5,7-Dihydroxy-2-(1-hydroxy-3,5-dimethoxy-4-oxocyclohex-2-en-1-yl)chromen-4-one
2-(2,5-Dihydroxy-4-methoxyphenyl)-3,5,6,7-tetrahydroxychromen-4-one
7-chloro-5-(2-chlorophenyl)-3-methoxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde
adenosine 5-monophosphate(1+)
C10H15N5O7P (348.07090700000003)
An organic cation that is the conjugate acid of adenosine 5-monophosphate (AMP) obtained by selective protonation at position N1 on the purine moiety.
BPR1M97
BPR1M97 is a dual-acting mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptor agonist with Ki values of 1.8 and 4.2 nM, respectively. BPR1M97 shows high potency and blood-brain barrier penetration, and produces potent antinociceptive effects[1].
(1r,5r,6s)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol
1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione
7,13,17-trihydroxy-12-oxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1,3,5,7,10,16,18,20-octaene-9,15-dione
(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7,8-dimethoxy-2,3-dihydro-1-benzopyran-4-one
[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]acetic acid
(7e,13e,17e)-18-bromooctadeca-7,13,17-trien-5,15-diynoic acid
(1s,2r,2'r,4s,4's,5's,6r)-5'-bromo-4'-chloro-1,4,4'-trimethyl-3-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexan]-2'-ol
13-chloro-6,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-15-carbaldehyde
2,5,7-trihydroxy-3-[hydroxy(4-hydroxyphenyl)methyl]-6-methoxy-2,3-dihydro-1-benzopyran-4-one
(4s,6s,8r)-8,10,16,18-tetrahydroxy-5-oxahexacyclo[11.7.1.0²,¹².0³,⁹.0⁴,⁶.0¹⁷,²¹]henicosa-1(21),2,9,11,13,15,17,19-octaen-7-one
(2r,3s)-3,5,7-trihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(1s,5r,9r,13s,14r)-11,14,16-trihydroxy-10,17-dimethyl-3,7-dioxapentacyclo[11.4.0.0¹,⁵.0⁵,⁹.0⁹,¹⁴]heptadeca-10,16-diene-4,12,15-trione
(5r,6r)-6-{2-[(1e)-1-(5-chloro-1h-pyrrol-2-yl)prop-1-en-2-yl]-1,3-oxazol-4-yl}-4-methoxy-5-methyl-5,6-dihydropyran-2-one
3,5,7-trihydroxy-6,8-dimethyl-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(2r)-2-hydroxy-4-{5'-methyl-[2,2'-bithiophen]-5-yl}but-3-yn-1-yl 3-methylbutanoate
C18H20O3S2 (348.08538100000004)
(1r,5r,8s,11r)-5-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-11-hydroxy-3,9-dioxatricyclo[6.3.0.0¹,⁵]undecane-4,10-dione
butyl 7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate
10-bromo-11-methoxy-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene
6-{2-[1-(5-chloro-1h-pyrrol-2-yl)prop-1-en-2-yl]-1,3-oxazol-4-yl}-4-methoxy-5-methyl-5,6-dihydropyran-2-one
(8bs,8cr)-1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione
methyl 13-hydroxy-2,6-dimethoxy-11-methyl-4-oxo-3,10-dioxatricyclo[7.4.1.0⁵,¹⁴]tetradeca-1(13),5,7,9(14),11-pentaene-8-carboxylate
2-hydroxy-6-[2-hydroxy-4-methoxy-6-(methoxycarbonyl)phenoxy]-4-methylbenzoic acid
5'-bromo-4'-chloro-1,4,4'-trimethyl-3-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexan]-2'-ol
butyl (1s)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate
(11r,13e)-4-chloro-5,7-dihydroxy-11-methyl-10,19-dioxatricyclo[14.2.1.0³,⁸]nonadeca-1(18),3,5,7,13,16-hexaen-9-one
(2s,3r)-5,7,8-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-methoxy-2,3-dihydro-1-benzopyran-4-one
8,10,16,18-tetrahydroxy-5-oxahexacyclo[11.7.1.0²,¹².0³,⁹.0⁴,⁶.0¹⁷,²¹]henicosa-1(20),2,9,11,13(21),14,16,18-octaen-7-one
4'-ethyl 4-methyl 2,3',5',6-tetrahydroxy-[1,1'-biphenyl]-4,4'-dicarboxylate
(2s,3s,4s)-3,6-dihydroxy-8-methoxy-2-methyl-5,10-dioxo-2h,3h,4h-naphtho[2,3-b]pyran-4-yl acetate
(7ar,8ar,8bs,8cr)-1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione
11,14,16-trihydroxy-10,17-dimethyl-3,7-dioxapentacyclo[11.4.0.0¹,⁵.0⁵,⁹.0⁹,¹⁴]heptadeca-10,16-diene-4,12,15-trione
2-chloro-1,3,8-trihydroxy-6-(2-hydroxypropyl)anthracene-9,10-dione
4-(4-carboxy-2-methoxyphenoxy)-3,5-dimethoxybenzoic acid
3,6-dihydroxy-1a,7a-dihydro-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-7-one
5,7'-dihydroxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione
2-hydroxy-4-{5'-methyl-[2,2'-bithiophen]-5-yl}but-3-yn-1-yl 3-methylbutanoate
C18H20O3S2 (348.08538100000004)
(1r,5s,6r,8r,9s)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol
3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol
(1s,3s,4r,6s,8s,9r)-3-bromo-4-chloro-4,12,12-trimethyl-11-methylidene-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-9-ol
(2r,4s)-4,5,10-trihydroxy-8-methoxy-2-(2-oxopropyl)-2h,3h,4h-naphtho[2,3-b]pyran-6,9-dione
3-bromo-4-chloro-4,12,13,13-tetramethyl-7,11-dioxatetracyclo[6.4.1.0¹,⁶.0¹⁰,¹²]tridecane
(2r,3r)-3,5,7-trihydroxy-6,8-dimethyl-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
16-(2h-1,3-benzodioxol-5-yl)-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-14-one
8,12,17-trihydroxypentacyclo[10.7.1.0²,¹¹.0⁴,⁹.0¹³,¹⁸]icosa-2(11),4,6,8,13,15,17-heptaene-3,10,19-trione
methyl 4-chloro-8-hydroxy-3-methoxy-6-methyl-9-oxoxanthene-1-carboxylate
n-{2-[6-bromo-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]ethyl}-n-methylformamide
(13r)-7,13,17-trihydroxy-12-oxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1,3,5,7,10,16,18,20-octaene-9,15-dione
3-bromo-4-chloro-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-10-one
(1as,7ar)-3,6-dihydroxy-1a,7a-dihydro-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-7-one
methyl (2r)-13-hydroxy-2,6-dimethoxy-11-methyl-4-oxo-3,10-dioxatricyclo[7.4.1.0⁵,¹⁴]tetradeca-1(13),5,7,9(14),11-pentaene-8-carboxylate
(1r,1'r,10'r,12'r)-5,7'-dihydroxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione
(3r,3'r,4's)-3'-bromo-1-chloro-2',2',6-trimethyl-6'-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-3,1'-cyclohexan]-4'-ol
2-amino-6-hydroxy-8-(4-hydroxybenzoyl)phenoxazin-3-one
C19H12N2O5 (348.07461820000003)
3,4,7,8-tetrahydroxy-10h,11h-cyclohexa[j]fluoranthene-9,12-dione
2-amino-5-(5-carboxy-6-hydroxy-4-imino-3-oxocyclohexa-1,5-dien-1-yl)-6-hydroxy-3-methoxybenzoic acid
(2s,3r,5r,12s,13r,15r)-8,18-dihydroxy-4,14-dioxaheptacyclo[10.8.1.1²,⁷.0³,⁵.0¹³,¹⁵.0¹⁷,²¹.0¹¹,²²]docosa-1(21),7(22),8,10,17,19-hexaene-6,16-dione
(2s,4r)-4,5,10-trihydroxy-8-methoxy-2-(2-oxopropyl)-2h,3h,4h-naphtho[2,3-b]pyran-6,9-dione
15-hydroxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2(10),3,8,11,14(22),15,17(21),23-nonaen-24-ium
[C20H14NO5]+ (348.08719340000005)